Departments
What we are doing:
PTC's laboratories have three main departments:
Anti-cancer Drug Formulation Department
Anti-cancer Drug Analysis Department
PTC's Analysis Areas:
- Analytical and Bioanalytical method development and validation
- QbD-based analytical method optimization
- Impurity Profiling
- Development and validation of stability indicating analytical methods
- Development and evaluation of anti-cancer drugs/ formulations for heavy metal toxicity.
Anti-cancer drugs Stability Study Department
A stability study is a vital stake in the anti-cancer drug development process. Stability is the only way that assures whether the anti-cancer drug is within acceptance criteria or not. Stability comes into focus when the quality and efficiency of the anti-cancer drug are concerned.
PTC ‘s stability study department provides the necessary data for the shipping and distribution of anti-cancer drug products. In this department, three ensured stabilities are studied which are physical, chemical, and microbiological.
In PTC, a stability study is performed at various stages of the anti-cancer drug development process. At the early stage of drug development, accelerated stability studies are performed to find out the rate of degradation of the product if stored for a longer period under specific conditions. After that, a forced degradation study is carried out to check the effect of stressed external conditions on the drug product.
In our PTC's stability department, we are mainly concerned with the following types of stability studies:
- Long-term stability
- Intermediate stability
- Accelerated stability
- In-use stability